M
Metabolize
United States · Healthtech
Develops consumer metabolic-health products based on licensed Stanford-originated research.
Product
Metabolize is a San Francisco consumer health company developing products from naturally occurring metabolites. It holds an exclusive licence to intellectual property originating in Stanford research.
Its first planned product, NatLean, is a dietary supplement intended for people transitioning off GLP-1 therapies. The company is preparing commercialization while continuing product validation and manufacturing work.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Seed | $3.2M | Astanor — LeadLongGame — ParticipantMaia Ventures — ParticipantSOSV — Participant |